Results 141 to 150 of about 224,676 (168)

Effects of pulse glucocorticoid treatment on retinal blood flow in patients with active Graves' orbitopathy. [PDF]

BMC Ophthalmol
Mohammadi H, Güneş İB, Arı Ş.
europepmc   +1 more source

Role of the suppressor of cytokine signaling-3 in the pathogenesis of Graves' orbitopathy. [PDF]

Front Endocrinol (Lausanne)
Kim W, Seo MK, Kim YJ, Choi SH, Ku CR, Kim S, Lee EJ, Yoon JS.   +7 more
europepmc   +1 more source

A randomized controlled trial on the effect of hydroxychloroquine in mild Graves' orbitopathy (GO-HCQ): study protocol. [PDF]

Trials
Lin CH, Wei YH, Lu JY, Li HY, Lee CW, Yang CY, Chang CH, Wu WC, Wang CY, Shih SR.   +9 more
europepmc   +1 more source

MMP14 as a central mediator of TGF-β1-induced extracellular matrix remodeling in graves' orbitopathy. [PDF]

Front Endocrinol (Lausanne)
Wang X, Lu J, He Y, Shu Q, Lin Y, Su W, Wang P.   +6 more
europepmc   +1 more source

Statin Use and the Risk of Developing Graves' Orbitopathy in Patients With Graves' Disease: A Systematic Review and Meta-Analysis With Regional and Gender-Stratified Analyses. [PDF]

Cureus
Kermaj M, Hakkeem B, Fero H, Doddapaneni VK, Ylli A.   +4 more
europepmc   +1 more source

[New Onset of Graves' Orbitopathy Following Bendamustine-Rituximab (BR) therapy in a Patient with Chronic Lymphocytic Leukemia: A Case Report and Literature Review]. [PDF]

Probl Endokrinol (Mosk)
Kozlov ED, Bessmertnaya EG, Chandola SS, Yamashkina EI.   +3 more
europepmc   +1 more source

Novel immunoinflammatory blood markers in Graves' orbitopathy: insights into activity and severity. [PDF]

BMJ Open Ophthalmol
Abounoori M, Pourazizi M, Bahmani Kashkouli M, Akha O, Jafari R, Movahedirad M.   +5 more
europepmc   +1 more source

Unilateral Graves' Orbitopathy in a Patient with Marine-Lenhart Syndrome: A case report. [PDF]

Sultan Qaboos Univ Med J
Alfutaisi A, Osman A, Al Siyabi ZS, Al Senani OS, Bahowairath F, Al Farqani A, Al Rasbi SK.   +6 more
europepmc   +1 more source

Natural history of graves’ orbitopathy after treatment

Endocrine, 2016
Intravenous glucocorticoids are used for Graves’ orbitopathy, alone or associated with/followed by additional treatments (orbital radiotherapy, orbital decompression, palpebral or eye surgery).
Claudio Marcocci, Paolo Vitti, Michele Marino   +2 more
exaly   +2 more sources